PerkinElmer Aktie
WKN: 850943 / ISIN: US7140461093
|
02.02.2026 12:16:52
|
Revvity Guides FY26 Above Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Monday, biotechnology company Revvity, Inc. (RVTY) initiated its adjusted earnings and total revenue guidance for the full-year 2026.
For fiscal 2026, the company now projects adjusted earnings in a range of $5.35 to $5.45 per share on total revenues between $2.96 billion and $2.99 billion.
On average, analysts polled expect the company to report earnings of $5.32 per share on revenues of $2.94 billion for the year. Analysts' estimates typically exclude special items.
In Monday's pre-market trading, RVTY is trading on the NYSE at $109.94, up $1.14 or 1.05 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PerkinElmer Inc.
Analysen zu PerkinElmer Inc.
Aktien in diesem Artikel
| PerkinElmer Inc. | 74,76 | 1,69% |
|